Accéder au contenu
Merck

miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1.

Science advances (2020-06-05)
Fumihiko Urabe, Nobuyoshi Kosaka, Yurika Sawa, Yusuke Yamamoto, Kagenori Ito, Tomofumi Yamamoto, Takahiro Kimura, Shin Egawa, Takahiro Ochiya
RÉSUMÉ

Extracellular vesicles (EVs) are involved in intercellular communication during cancer progression; thus, elucidating the mechanism of EV secretion in cancer cells will contribute to the development of an EV-targeted cancer treatment. However, the biogenesis of EVs in cancer cells is not fully understood. MicroRNAs (miRNAs) regulate a variety of biological phenomena; thus, miRNAs could regulate EV secretion. Here, we performed high-throughput miRNA-based screening to identify the regulators of EV secretion using an ExoScreen assay. By using this method, we identified miR-26a involved in EV secretion from prostate cancer (PCa) cells. In addition, we found that SHC4, PFDN4, and CHORDC1 genes regulate EV secretion in PCa cells. Furthermore, the progression of the PCa cells suppressing these genes was inhibited in an in vivo study. Together, our findings suggest that miR-26a regulates EV secretion via targeting SHC4, PFDN4, and CHORDC1 in PCa cells, resulting in the suppression of PCa progression.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
MISSION® esiRNA, targeting human TSG101
Sigma-Aldrich
MISSION® esiRNA, targeting human PRKCD
Sigma-Aldrich
MISSION® esiRNA, targeting human SMPD3
Sigma-Aldrich
MISSION® esiRNA, targeting human CHORDC1
Sigma-Aldrich
MISSION® esiRNA, targeting human PFDN4
Sigma-Aldrich
MISSION® esiRNA, targeting human STEAP3, STEAP3-AS1
Sigma-Aldrich
MISSION® esiRNA, targeting human SHC4